TW200612943A - 4-trifluoromethoxyphenoxybenzene-4'-sulfonic acids, process for their preparation and use in medicaments - Google Patents
4-trifluoromethoxyphenoxybenzene-4'-sulfonic acids, process for their preparation and use in medicamentsInfo
- Publication number
- TW200612943A TW200612943A TW094121522A TW94121522A TW200612943A TW 200612943 A TW200612943 A TW 200612943A TW 094121522 A TW094121522 A TW 094121522A TW 94121522 A TW94121522 A TW 94121522A TW 200612943 A TW200612943 A TW 200612943A
- Authority
- TW
- Taiwan
- Prior art keywords
- medicaments
- preparation
- trifluoromethoxyphenoxybenzene
- sulfonic acids
- sulfonamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004031620A DE102004031620A1 (de) | 2004-06-30 | 2004-06-30 | 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200612943A true TW200612943A (en) | 2006-05-01 |
Family
ID=34970397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094121522A TW200612943A (en) | 2004-06-30 | 2005-06-28 | 4-trifluoromethoxyphenoxybenzene-4'-sulfonic acids, process for their preparation and use in medicaments |
Country Status (21)
Country | Link |
---|---|
US (2) | US20070155778A1 (zh) |
EP (1) | EP1763515B1 (zh) |
JP (1) | JP4871273B2 (zh) |
KR (1) | KR20070026662A (zh) |
CN (1) | CN101035764A (zh) |
AR (1) | AR049557A1 (zh) |
AT (1) | ATE388940T1 (zh) |
AU (1) | AU2005259634A1 (zh) |
BR (1) | BRPI0512656A (zh) |
CA (1) | CA2572126A1 (zh) |
DE (2) | DE102004031620A1 (zh) |
DK (1) | DK1763515T3 (zh) |
ES (1) | ES2299039T3 (zh) |
IL (1) | IL179975A0 (zh) |
MX (1) | MXPA06014189A (zh) |
MY (1) | MY139236A (zh) |
PE (1) | PE20060478A1 (zh) |
PT (1) | PT1763515E (zh) |
TW (1) | TW200612943A (zh) |
UY (1) | UY28994A1 (zh) |
WO (1) | WO2006002764A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
DE102005002500A1 (de) | 2005-01-19 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen |
CN101680157B (zh) | 2007-05-31 | 2012-03-28 | 皇家飞利浦电子股份有限公司 | 用于熨烫系统的固定设备 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9611479B1 (pt) * | 1995-11-13 | 2009-01-13 | Ácidos alfa-iminoidroxÂmicos e carboxÍlicos n-substituÍdos cÍclicos e heterocÍclicos. | |
ES2201318T3 (es) * | 1996-08-28 | 2004-03-16 | THE PROCTER & GAMBLE COMPANY | Inhibidores de metaloproteasas de aminas ciclicas substituidas. |
WO1998050348A1 (en) * | 1997-05-09 | 1998-11-12 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6294573B1 (en) * | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
BR9814643A (pt) * | 1997-11-14 | 2000-10-03 | Searle & Co | Inibidor de metaloprotease de ácido sulfona hidroxâmico aromático |
US20010039287A1 (en) * | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
DE102004031850A1 (de) * | 2004-06-30 | 2006-01-26 | Sanofi-Aventis Deutschland Gmbh | Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
-
2004
- 2004-06-30 DE DE102004031620A patent/DE102004031620A1/de not_active Withdrawn
-
2005
- 2005-06-15 AU AU2005259634A patent/AU2005259634A1/en not_active Abandoned
- 2005-06-15 ES ES05750284T patent/ES2299039T3/es active Active
- 2005-06-15 CN CNA2005800218369A patent/CN101035764A/zh active Pending
- 2005-06-15 KR KR1020067027482A patent/KR20070026662A/ko not_active Application Discontinuation
- 2005-06-15 EP EP05750284A patent/EP1763515B1/de not_active Not-in-force
- 2005-06-15 DE DE502005003219T patent/DE502005003219D1/de active Active
- 2005-06-15 WO PCT/EP2005/006416 patent/WO2006002764A1/de active IP Right Grant
- 2005-06-15 MX MXPA06014189A patent/MXPA06014189A/es active IP Right Grant
- 2005-06-15 DK DK05750284T patent/DK1763515T3/da active
- 2005-06-15 JP JP2007518485A patent/JP4871273B2/ja not_active Expired - Fee Related
- 2005-06-15 AT AT05750284T patent/ATE388940T1/de not_active IP Right Cessation
- 2005-06-15 CA CA002572126A patent/CA2572126A1/en not_active Abandoned
- 2005-06-15 BR BRPI0512656-8A patent/BRPI0512656A/pt not_active IP Right Cessation
- 2005-06-15 PT PT05750284T patent/PT1763515E/pt unknown
- 2005-06-23 PE PE2005000727A patent/PE20060478A1/es not_active Application Discontinuation
- 2005-06-28 AR ARP050102660A patent/AR049557A1/es not_active Application Discontinuation
- 2005-06-28 TW TW094121522A patent/TW200612943A/zh unknown
- 2005-06-29 MY MYPI20052975A patent/MY139236A/en unknown
- 2005-06-30 UY UY28994A patent/UY28994A1/es unknown
-
2006
- 2006-12-11 IL IL179975A patent/IL179975A0/en unknown
- 2006-12-15 US US11/611,199 patent/US20070155778A1/en not_active Abandoned
-
2009
- 2009-12-21 US US12/643,162 patent/US20100099663A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MY139236A (en) | 2009-09-30 |
ES2299039T3 (es) | 2008-05-16 |
DE102004031620A1 (de) | 2006-02-02 |
PT1763515E (pt) | 2008-04-07 |
DK1763515T3 (da) | 2008-06-16 |
JP2008504316A (ja) | 2008-02-14 |
US20070155778A1 (en) | 2007-07-05 |
UY28994A1 (es) | 2006-01-31 |
EP1763515B1 (de) | 2008-03-12 |
AR049557A1 (es) | 2006-08-16 |
KR20070026662A (ko) | 2007-03-08 |
MXPA06014189A (es) | 2007-03-12 |
PE20060478A1 (es) | 2006-06-22 |
BRPI0512656A (pt) | 2008-04-01 |
DE502005003219D1 (de) | 2008-04-24 |
AU2005259634A1 (en) | 2006-01-12 |
ATE388940T1 (de) | 2008-03-15 |
IL179975A0 (en) | 2007-05-15 |
WO2006002764A1 (de) | 2006-01-12 |
CA2572126A1 (en) | 2006-01-12 |
CN101035764A (zh) | 2007-09-12 |
JP4871273B2 (ja) | 2012-02-08 |
US20100099663A1 (en) | 2010-04-22 |
EP1763515A1 (de) | 2007-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY143565A (en) | Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof | |
NL300933I2 (nl) | Letermovir | |
WO2007065664A3 (en) | Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors | |
WO2007025709A3 (en) | Organic compounds | |
CY1112831T1 (el) | Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh | |
MY137039A (en) | Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof | |
EA200970149A1 (ru) | Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
WO2006077025A3 (en) | Morpholines as 5ht2c agonists | |
RS41104A (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
BRPI0518231A2 (pt) | derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica | |
TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
ECSP067111A (es) | Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica | |
TW200639156A (en) | New compounds | |
MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
UY29859A1 (es) | Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica | |
SE0403171D0 (sv) | New compounds | |
NO20063865L (no) | Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
NO20063859L (no) | Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter | |
MX2009000768A (es) | Lactamas macrociclicas. | |
UA93529C2 (ru) | Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами | |
WO2008009750A3 (en) | Macrocyclic compounds useful as bace inhibitors | |
GB0602951D0 (en) | Organic Compounds | |
TW200612943A (en) | 4-trifluoromethoxyphenoxybenzene-4'-sulfonic acids, process for their preparation and use in medicaments |